Johnson & Johnson Innovation – JJDC has co-led the computational pathology technology provider's series C round to take its total funding to $195m.

Luba Greenwood has been brought on to run Binney Street Capital on behalf of cancer research and care provider Dana-Farber Cancer Institute.

The stem cell therapy developer has filed to go public seven months after closing $700m in funding from investors including Alphabet unit GV.

The Eli Lilly and Wuxi AppTec-backed oncology drug developer has raised the money from new and existing backers, and will use the cash to boost its product pipeline.

Johnson & Johnson Innovation – JJDC co-led the computational pathology technology provider's series C round to take its total funding to $195m.

Atalanta Therapeutics has launched out of UMass with $110m in combined series A and partnership funding to develop therapies for neurodegenerative diseases.

Three years after launching to commercialise stem cell research from Harvard University, Sana has filed for an initial public offering.

Luba Greenwood has been brought on to run Binney Street Capital on behalf of cancer research and care provider Dana-Farber Cancer Institute.

The Intel-backed healthcare analytics technology provider has closed a new round with investments from AllegisNL Capital and Blue Venture Fund.

Guardian Strategic Ventures and Unum Business Ventures helped the healthcare benefits management service close its series A round at $11m.